Kodiak Sciences Inc. (KOD)
KOD Stock Price Chart
Explore Kodiak Sciences Inc. interactive price chart. Choose custom timeframes to analyze KOD price movements and trends.
KOD Company Profile
Discover essential business fundamentals and corporate details for Kodiak Sciences Inc. (KOD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Oct 2018
Employees
109.00
Website
https://kodiak.comCEO
Victor Perlroth
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
KOD Financial Timeline
Browse a chronological timeline of Kodiak Sciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$1.05.
Earnings released on 13 Aug 2025
EPS came in at -$1.03 falling short of the estimated -$1.01 by -1.98%.
Earnings released on 14 May 2025
EPS came in at -$1.09 falling short of the estimated -$0.89 by -22.47%.
Earnings released on 27 Mar 2025
EPS came in at -$0.84 surpassing the estimated -$0.90 by +6.67%.
Earnings released on 14 Nov 2024
EPS came in at -$0.84 surpassing the estimated -$0.90 by +6.67%.
Earnings released on 14 Aug 2024
EPS came in at -$0.86 surpassing the estimated -$0.87 by +1.15%.
Earnings released on 15 May 2024
EPS came in at -$0.82 surpassing the estimated -$1.09 by +24.77%.
Earnings released on 28 Mar 2024
EPS came in at -$1.13 falling short of the estimated -$0.86 by -31.40%.
Earnings released on 14 Nov 2023
EPS came in at -$0.95 surpassing the estimated -$1.41 by +32.62%.
Earnings released on 14 Aug 2023
EPS came in at -$1.53 falling short of the estimated -$1.23 by -24.39%.
Earnings released on 15 May 2023
EPS came in at -$1.35 falling short of the estimated -$1.28 by -5.47%.
Earnings released on 28 Mar 2023
EPS came in at -$1.35 surpassing the estimated -$1.58 by +14.56%.
Earnings released on 9 Nov 2022
EPS came in at -$1.47 surpassing the estimated -$1.82 by +19.23%.
Earnings released on 9 Aug 2022
EPS came in at -$1.74 surpassing the estimated -$1.77 by +1.69%.
Earnings released on 10 May 2022
EPS came in at -$1.83 falling short of the estimated -$1.39 by -31.65%.
Earnings released on 1 Mar 2022
EPS came in at -$1.79 falling short of the estimated -$1.29 by -38.76%.
Stock split effective on 23 Feb 2022
Shares were split 5 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Nov 2021
EPS came in at -$1.30 falling short of the estimated -$1.16 by -12.07%.
Earnings released on 9 Aug 2021
EPS came in at -$1.08 falling short of the estimated -$1.04 by -3.85%.
Earnings released on 10 May 2021
EPS came in at -$0.98 falling short of the estimated -$0.94 by -4.26%.
Earnings released on 1 Mar 2021
EPS came in at -$0.97 falling short of the estimated -$0.87 by -11.49%.
Earnings released on 9 Nov 2020
EPS came in at -$0.80 falling short of the estimated -$0.67 by -19.40%.
KOD Stock Performance
Access detailed KOD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.